EST Cathie Wood’s ARK Investment buys 370K shares of 10x Genomics (TXG) todayInvest with Confidence: Follow TipRanks' Top Wall Street ...

Cathie Wood's ARK ETFs have made their daily trades public for Wednesday, 29 January 2025, showcasing a series of strategic moves in the tech and biotech sectors. The most significant purchase was in ...

Cathie Wood-led Ark Invest made significant trades involving CRSP, TXG, RBLX, ACHR, NU, ADYEY, ACCD, and AVAV.

Cathie Wood's ARK ETFs have made their daily ... ARK also continued to increase its holdings in 10X GENOMICS INC (NASDAQ:TXG) with a total buy worth $5,488,217, reinforcing a trend as the company ...

Renowned investor Cathie Wood, CEO of Ark Invest believes President Donald Trump's second administration could breathe new ...

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...

Investing guru Cathie Wood remains an investor favorite ... investments in her “Big Ideas” monograph. Whether it is genomics, precision therapeutics, or artificial intelligence, her ETFs ...

10x Genomics excels in single-cell and spatial technologies but faces significant challenges. Despite an EPS beat, revenue fell 1% due to sales disruption and competitive pricing. The company's ...

Across the recent three months, 6 analysts have shared their insights on 10x Genomics (NASDAQ:TXG), expressing a variety of opinions spanning from bullish to bearish. The table below summarizes ...

Cathie Wood's ARK Investment Management adds to its ... CEO Eric Lefkofsky highlights strong growth in genomics revenue, up 30%, and data and services revenue, which climbs 45%.